文献速递乳房整形与再造美容整形

回归基础:术前皮肤消毒剂能否帮助预防生物膜相关包膜挛缩?

Back to Basics: Could the Preoperative Skin Antiseptic Agent Help Prevent Biofilm-Related Capsular Contracture?
PubMed 文献 · Aesthet Surg J · 2019-01-01

该研究回顾性分析了63例经乳晕入路初次隆乳患者,前6个月32例使用聚维酮碘(PVP-I),后31例使用氯己定葡萄糖酸盐(CHG)进行术前皮肤消毒。结果显示PVP-I组包膜挛缩比例更高,CHG组无包膜挛缩发生,提示CHG可能更有效预防生物膜相关包膜挛缩。

要点

  • 经乳晕入路初次隆乳中,CHG术前消毒组包膜挛缩比例为0,PVP-I组更高。
  • 包膜挛缩主要与细菌生物膜相关,常见菌为表皮葡萄球菌等皮肤常驻菌。
  • 研究支持在无含醇消毒剂时选用CHG进行术前皮肤准备。

核心结论

  • CHG作为初次隆乳术前皮肤消毒剂,比PVP-I更有效帮助预防生物膜相关包膜挛缩。

研究设计与样本

  • 回顾性病历 review,共63例经乳晕入路初次隆乳患者,2014年前6个月32例用PVP-I,后31例用CHG。

主要发现

  • Pearson卡方检验显示两亚组包膜挛缩比例差异有统计学意义。
  • PVP-I组包膜挛缩比例更高,CHG组无包膜挛缩发生。

关键数值与推荐

  • 文献复习显示,Baker III-IV级包膜挛缩患者取出的包膜和假体中超过90%的细菌属于皮肤常驻微生物群,以表皮葡萄球菌为主。
  • 2014年6月美国医疗流行病学学会建议,在无含醇消毒剂时使用CHG进行术前皮肤准备以预防手术部位感染。

临床怎么用

  • 经乳晕入路初次隆乳可考虑使用CHG进行术前皮肤消毒,以降低生物膜相关包膜挛缩风险。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Capsular contracture (CC) has remained an unresolved issue throughout history. Strong evidence focuses on bacterial biofilm as its main source. A literature review revealed that more than 90% of bacteria found in capsules and implants removed from patients with Baker grade III-IV CC belong to the resident skin microbiome (Staphylococcus epidermidis, predominant microorganism). The use of an adequate preoperative skin antiseptic may be a critical step to minimize implant contamination and help prevent biofilm-related CC. OBJECTIVES: The authors sought to compare the effect of 2 different antiseptic skin preparations: povidone-iodine (PVP-I) vs chlorhexidine gluconate (CHG) on CC proportions after primary breast augmentation through a periareolar approach. METHODS: In June of 2014, The Society for Healthcare Epidemiology of America proposed to use CHG for preoperative skin preparation in the absence of alcohol-containing antiseptic agents as strategy to prevent surgical site infection. The clinical safety committee of a surgical center in Colombia decided to change PVP-I to CHG for surgical site preparation thereafter. The medical records of 63 patients who underwent to primary breast augmentation through a periareolar approach during 2014 were reviewed. In the first 6 months PVP-I was used in 32 patients, and later CHG was employed in 31 patients. RESULTS: Pearson's chi-squared test to compare CC proportions between subgroups showed a statistically significant difference. The CC proportion was higher for patients who had antisepsis with PVP-I. CC was absent when CHG was employed. CONCLUSIONS: CHG as preoperative skin antiseptic for primary breast augmentation surgery was more effective than PVP-I to help prevent biofilm-related CC.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Carvajal J, Carvajal M, Hernández G, et al. Back to Basics: Could the Preoperative Skin Antiseptic Agent Help Prevent Biofilm-Related Capsular Contracture? Aesthet Surg J. 2019. PMID: 30137191. doi:10.1093/asj/sjy216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。